To mark the 25th anniversary of a landmark framework in cancer research, Cell has published a special issue devoted to the biological processes that drive cancer and their therapeutic implications.
Read moreAstaxanthin is a naturally occurring xanthophyll carotenoid that has gained significant scientific attention due to its exceptional antioxidant activity, molecular stability and broad application pote...
Read moreWith this capital injection, the biotechnology company covers its financial requirements to complete the preclinical development and the first clinical trial of ITR-251, a novel drug for the treatment...
Read moreScientist at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) and the Institute for Research in Biomedicine (IRB Barcelona) uncover a key metabolic mechanism governing immune ...
Read moreUn equipo investigador de la Universidad de León (ULE) ha publicado un estudio en el que identifica tres microARN humanos capaces de reducir la infección intracelular causada por Staphylococcus aure...
Read moreHow sponsors can leverage both the EU Clinical Trials Regulation and UK’s reformed framework to achieve cost efficiencies, faster timelines, and stronger regulatory positioning.
Read moreValidan una tecnología basada en la respuesta inmunitaria para anticipar la evolución clínica en pacientes con sepsis atendidos en urgencias y en unidades de cuidados intensivos
Read morePalmitic acid, a saturated fatty acid widely found in foods, is associated with impaired insulin sensitivity, whereas oleic acid, abundant in olive oil, may have a protective effect against these meta...
Read moreResearchers have identified more than 600,000 microbial proteins capable of breaking down natural and synthetic plastics, revealing a far broader biodegradation potential across microbes than previous...
Read moreHan identificado una posible asociación entre una variante del ADN mitocondrial (m.11232T>C) y complicaciones neurológicas graves tras la exposición a anestesia general en pacientes pediátricos
Read moreCurapath has partnered with Nacalai Tesque to expand access to its portfolio of next-generation polymers and PEG-free shielding lipids for advanced drug delivery applications in Japan.
Read moreProceeds to support the advancement of three first- and best-in-class ADC programs through upcoming clinical milestones
Read more